Patent · US Expired

Monoclonal antibodies that bind OCIF

US6919434B1 · kind B1 · utility

53Cited by
11References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 1999
Grant dateJul 19, 2005
Priority date
Expiry dateJun 23, 2019

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A protein which inhibits osteoclast diffraction and/or maturation and a method for producing the protein. The protein is produced by human embryonic lung fibroblasts and has a molecular weight of about 60 kD and about 120 kD under non-reducing conditions and about 60 kD under reducing conditions an SDS-polyacrylamide gel electrophoresis. The protein can be isolated and purified from the culture medium of fibroblasts. Furthermore, the protein can be produced by gene engineering. The present invention includes cDNA for producing the protein by gene engineering, antibodies having specific affinity for the protein or a method for determining protein concentration using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.